JYNT
Next earnings: Aug 6, 2026 · After close
Signal
Mixed11
Price
1
Move+0.24%Quiet session
Volume
1
Volume2.0× avgHeavy volume
Technical
1
RSIRSI 38Momentum negative
PRICE
Prev Close
8.21
Open
8.27
Day Range8.17 – 8.48
8.17
8.48
52W Range7.50 – 13.47
7.50
13.47
12% of range
VOLUME & SIZE
Avg Volume
64.8K
FUNDAMENTALS
P/E Ratio
91.4x
Premium valuation
EPS (TTM)
Div Yield
No dividend
Beta
1.73
High vol
Performance
1D
+0.24%
5D
-9.36%
1M
-9.36%
3M
-5.18%
6M
+0.12%
YTD
-5.62%
1Y
-18.60%
Best: 1D (+0.24%)Worst: 1Y (-18.60%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +222% YoY · 80% gross margin
Valuation
EXPENSIVE
P/E 91x vs ~20x sector
Health
STRONG
CR 1.6 · FCF $0.19/sh
Bullish
Key MetricsTTM
Market Cap$117.32M
Revenue TTM$56.64M
Net Income TTM$3.24M
Free Cash Flow$2.66M
Gross Margin79.9%
Net Margin5.7%
Operating Margin1.2%
Return on Equity16.9%
Return on Assets5.6%
Debt / Equity0.13
Current Ratio1.61
EPS TTM$0.23
Alpha SignalsFull Analysis →
What Moves This Stock

Net new clinic openings (franchise development pace): Target of 100+ annual openings drives long-term royalty base expansion

System-wide same-store sales growth: Directly impacts royalty revenue, reflects brand health and consumer demand trends

Company-owned clinic profitability trajectory: Path to positive EBITDA demonstrates unit economics viability

Franchise renewal rates and franchisee financial health: Indicates system sustainability and future royalty stream quality

Macro Sensitivity
Economic Cycle

moderate - Chiropractic care is partially discretionary (wellness-focused) but also addresses pain management needs. During recessions, cash-pay patients may defer routine visits, but The Joint's value positioning ($30-40 per visit vs. $100+ at traditional practices) provides defensive characteristics. Consumer spending trends and employment levels directly impact patient visit frequency and membership retention. However, the franchise model's recurring royalty structure provides more stability than pure consumer discretionary businesses.

Interest Rates

Moderate sensitivity through two channels: (1) Franchisee financing costs - rising rates increase borrowing costs for new clinic buildouts ($250K-350K initial investment), potentially slowing development pace; (2) Valuation multiple compression - as a growth story trading at high revenue multiples with negative earnings, rising rates reduce present value of future cash flows and compress comparable company multiples. Lower rates support franchisee expansion economics and improve stock valuation.

Key Risks

Regulatory changes to chiropractic scope of practice or state licensing requirements could limit service offerings or increase compliance costs across the franchise system

Shift toward integrated healthcare models and value-based care may favor insurance-accepting providers, potentially marginalizing cash-pay models if employer health plans expand chiropractic coverage

Saturation risk in core markets as clinic density increases, limiting same-store sales growth and franchisee returns in mature geographies

Investor Profile

growth - Investors are attracted to the long-term franchise expansion story (potential for 1,800+ U.S. clinics vs. ~700 today) and operating leverage inflection narrative. The stock appeals to small-cap growth investors willing to accept near-term losses for potential market share gains in fragmented chiropractic industry. High revenue multiple (94.8x P/S) reflects expectations for profitability inflection as scale is achieved. Not suitable for value or income investors given negative earnings and no dividend.

Watch on Earnings
Monthly system-wide same-store sales growth trends (leading indicator of royalty revenue)Net new clinic openings per quarter vs. guidance (development momentum)Company-owned clinic average weekly patient visits and revenue per visit (unit economics validation)Consumer sentiment index (UMCSENT) as proxy for discretionary healthcare spending appetite
Health Radar
3 strong1 watch2 concern
52/100
Liquidity
1.61Watch
Leverage
0.13Strong
Coverage
0.0xConcern
ROE
16.9%Strong
ROIC
2.3%Concern
Cash
$24MStrong
ANALYST COVERAGE8 analysts
BUY
+143.0%upside to target
Buy
563%
Hold
338%
5 Buy (63%)3 Hold (38%)0 Sell (-1%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
5/10
Technicals
RSI RangeRSI 38 — Bearish momentum
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 1.61 — healthy liquidity
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 107 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

PullbackGolden Cross · 50D leads 200D by 5.1%

-3.0% vs SMA 50 · +2.0% vs SMA 200

Momentum

RSI37.8
Momentum fading
MACD-0.06
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$13.47+63.7%
EMA 50
$8.72+5.9%
Current
$8.23
EMA 200
$8.07-1.9%
52W Low
$7.50-8.9%
52-Week RangeNear 52-week low
$7.5012th %ile$13.47
Squeeze SetupVolume-based
Distribution Pressure

Heavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.

20-Day Money Flow
Acc days:3
Dist days:2
Edge:+1 acc
Volume Context
Avg Vol (50D)69K
Recent Vol (5D)
118K+72%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 3 analysts
Analyst revisions:Revenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$120.1M
$116.8M$123.2M
-$0.97
±4%
Low2
FY2024
$119.2M
$117.1M$121.2M
-0.7%-$0.37
±5%
Moderate3
FY2025
$53.8M
$53.2M$54.5M
-54.8%-$0.04
±4%
Moderate3
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 4 consecutive quarters
Earnings HistoryJYNT
Last 8Q
+319.1%avg beat
Beat 5 of 8 quartersMissed 2 Estimates falling
-630%
Q3'24
+2732%
Q4'24
Q1'25
-50%
Q2'25
+14%
Q3'25
+300%
Q4'25
+20%
Q1'26
+167%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
B. RileyBuy → Neutral
Nov 7
DOWNGRADE
Wells FargoOverweight
Mar 13
UPGRADE
Cowen & Co.Outperform
Mar 13
UPGRADE
Maxim GroupBuy
Aug 5
UPGRADE
Insider Activity
SEC Filings →
6 Buys/0 SellsNet Buying
NET BUYERS$1.3M bought · $0 sold · 30d window
Jobson Charles E10 Percent Own…
$175K
May 13
BUY
Jobson Charles E10 Percent Own…
$1.1M
May 12
BUY
Jobson Charles E10 Percent Own…
$4K
Apr 21
BUY
Jobson Charles E10 Percent Own…
$131K
Feb 12
BUY
Jobson Charles E10 Percent Own…
$4K
Feb 11
BUY
Jobson Charles E10 Percent Own…
$7K
Jan 26
BUY
Financials

INSTITUTIONAL OWNERSHIP

1
Bandera Partners LLC
3.9M
2
Skylands Capital, LLC
893K
3
BlackRock, Inc.
755K
4
JCP Investment Management, LLC
594K
5
FIRST FOUNDATION ADVISORS
338K
6
Russell Investments Group, Ltd.
322K
7
GEODE CAPITAL MANAGEMENT, LLC
287K
8
STATE STREET CORP
286K
News & Activity

JYNT News

About

The Joint Corp. revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, the company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. With nearly 600 locations nationwide and over eight million patient visits annually, The Joint is a key leader in the chiropractic industry. Named on Franchise Times 'Top 200+ Franchises' and Entrepreneur's 'Franchise 500®' lists, The Joint Chiropractic is an innovative force, where healthcare meets retail.

Industry
Lessors of Nonfinancial Intangible Assets (except Copyrighted Works)
Ron StilwellSenior Vice President of Operations & Patient Experience
Sanjiv RazdanChief Executive Officer, President & Director
Steven KnaufVice President of Chiropractic & Compliance
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
JYNT
$8.23+0.24%$117M36.0+523.8%529.6%1500
$66.13-5.07%$13.0B+12626.1%-14525.8%1500
$94.92-3.79%$12.6B+3288.2%-4239.0%1500
$523.69-3.00%$12.1B+43205.3%-3008.0%1500
$227.72-1.30%$11.7B+6554.5%-2868.8%1500
$57.90-0.86%$11.2B50.3+1459.3%147.7%1500
$76.67-3.79%$10.8B+2325815.3%-19.7%1500
Sector avg-2.51%43.2+341924.6%-3426.3%1500